crinetics.com
Independent Directory - Important Information
This llms.txt file was publicly accessible and retrieved from crinetics.com. LLMS Central does not claim ownership of this content and hosts it for informational purposes only to help AI systems discover and respect website policies.
This listing is not an endorsement by crinetics.com and they have not sponsored this page. We are an independent directory service with no affiliation to the listed domain.
Copyright & Terms: Users should respect the original terms of service of crinetics.com. If you believe there is a copyright or terms of service violation, please contact us at support@llmscentral.com for prompt removal. Domain owners can also claim their listing.
Current llms.txt Content
Generated by Yoast SEO v25.8, this is an llms.txt file, meant for consumption by LLMs. The XML sitemap of this website can by found by following [this link](https://crinetics.com/sitemap_index.xml). # Crinetics: Driving the Next Generation of Endocrinology Care ## Pages - [Our Company](https://crinetics.com/our-company/) - [Contact Us](https://crinetics.com/contact/) - [Terms of Use](https://crinetics.com/terms/) - [Privacy Policy](https://crinetics.com/privacy-policy/) - [Therapeutic Areas](https://crinetics.com/clinical-development-therapeutic-areas/) - [Our Science](https://crinetics.com/focus-areas/) - [Pipeline](https://crinetics.com/pipeline/) - [Publications](https://crinetics.com/publications/) - [Featured Perspectives](https://crinetics.com/featured-perspectives/) - [Careers](https://crinetics.com/careers/) - [News \& Events](https://crinetics.com/news-events/) ## Posts - [Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635\(c\)\(4\)](https://crinetics.com/crinetics-pharmaceuticals-announces-november-2025-inducement-grants-under-nasdaq-listing-rule-5635c4/): Crinetics grants non\-qualified stock option awards to purchase an aggregate of 37,675 shares of its common stock and granted an aggregate of 25,300 restricted stock unit \(“RSU”\) awards to 11 new non\-executive employees - [Webcast: Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results](https://crinetics.com/webcast-crinetics-pharmaceuticals-to-report-third-quarter-2025-financial-results/): Crinetics company management will report third quarter 2025 financial results on Thursday, November 6, 2025 after the market closes\. - [Crinetics Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update](https://crinetics.com/crinetics-pharmaceuticals-reports-third-quarter-2025-financial-results-and-provides-business-update/): Crinetics Pharmaceuticals reports third quarter 2025 financial results and provided a business update on November 6, 2025 at 4:30PM ET\. - [NANETS 2025: Reimagining Treatment for Carcinoid Syndrome](https://crinetics.com/nanets-2025-reimagining-treatment-for-carcinoid-syndrome/) - [Crinetics to Highlight Neuroendocrine Tumor Research Progress at the 2025 North American Neuroendocrine Tumor Society Annual Meeting](https://crinetics.com/crinetics-to-highlight-neuroendocrine-tumor-research-progress-at-the-2025-north-american-neuroendocrine-tumor-society-annual-meeting/)
Version History
Categories
Visit Website
Explore the original website and see their AI training policy in action.
Visit crinetics.comContent Types
Recent Access
No recent access